The store will not work correctly when cookies are disabled.
2-(4-(2-(5-p-tolyl-1,3,4-oxadiazol-2-ylthio)ethoxy)benzylidene)malononitrile
ID: ALA2296211
PubChem CID: 76323998
Max Phase: Preclinical
Molecular Formula: C21H16N4O2S
Molecular Weight: 388.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(-c2nnc(SCCOc3ccc(C=C(C#N)C#N)cc3)o2)cc1
Standard InChI: InChI=1S/C21H16N4O2S/c1-15-2-6-18(7-3-15)20-24-25-21(27-20)28-11-10-26-19-8-4-16(5-9-19)12-17(13-22)14-23/h2-9,12H,10-11H2,1H3
Standard InChI Key: XEMVHRGBDDHGGX-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
4.0653 -20.6954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8807 -20.6965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2876 -19.9920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8802 -19.2859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0617 -19.2887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6585 -19.9938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1048 -19.9922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5842 -20.6506 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3624 -20.3981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3613 -19.5798 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5824 -19.3293 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0781 -20.7923 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.7776 -20.3699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7616 -19.5528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4611 -19.1304 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1767 -19.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1874 -20.3399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9022 -20.7345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6027 -20.3120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5839 -19.4908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8687 -19.0999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3188 -20.7056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0178 -20.2823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7339 -20.6759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0007 -19.4653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9868 -18.6526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4467 -21.0696 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8413 -19.9962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
8 9 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 2 0
23 24 1 0
23 25 1 0
25 26 3 0
24 27 3 0
6 28 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 388.45 | Molecular Weight (Monoisotopic): 388.0994 | AlogP: 4.65 | #Rotatable Bonds: 7 |
Polar Surface Area: 95.73 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.39 | CX LogD: 4.39 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.33 | Np Likeness Score: -1.79 |
References
1. Deora GS, Karthikeyan C, Moorthy NSHN, Rathore V, Rawat AK, Tamrakar AK, Srivastava AK, Trivedi P. (2013) Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B, 22 (11): [10.1007/s00044-013-0528-1] |